Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness.
暂无分享，去创建一个
[1] G. Sanders,et al. Cost-Effectiveness in Health and Medicine , 2016 .
[2] Bill Gates,et al. The next epidemic--lessons from Ebola. , 2015, The New England journal of medicine.
[3] R. Rappuoli,et al. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework , 2015 .
[4] Margaret Chan,et al. Ebola virus disease in West Africa--no early end to the outbreak. , 2014, The New England journal of medicine.
[5] M. Weinstein,et al. Legislating against use of cost-effectiveness information. , 2010, The New England journal of medicine.
[6] R. Keeney,et al. Advances in Decision Analysis: Practical Value Models , 2007 .
[7] F. Bator. American Economic Association The Simple Analytics of Welfare Maximization , 2007 .
[8] Rob Baltussen,et al. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .
[9] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[10] A. Garber,et al. Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.
[11] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[12] D. Canning,et al. The Value of Vaccination , 1884, The Dental Register.